← Back to Search

Behavioural Intervention

Interventional Cohort for Stroke

N/A
Waitlist Available
Research Sponsored by MedStar National Rehabilitation Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 4 (up to one week), week 8( up to one week)
Awards & highlights

Study Summary

This trial aims to study how two different high-intensity treadmill walking programs can help individuals who have had a Chronic Ischemic Stroke improve their walking abilities. Participants will be split into two groups, with

Who is the study for?
This trial is for adults over 18 who had a stroke more than 6 months ago and can walk at least 10 meters unassisted or with aids/bracing in under 180 seconds. It's not suitable for those who cannot meet these walking requirements.Check my eligibility
What is being tested?
The study compares two high-intensity treadmill training programs to see which one better improves walking abilities in chronic ischemic stroke survivors. One group will use blood flow restriction on the affected leg, while the other won't.See study design
What are the potential side effects?
Potential side effects may include muscle soreness, fatigue, discomfort from the blood flow restriction device, and possible skin irritation where the device is applied.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 4 (up to one week), week 8( up to one week)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 4 (up to one week), week 8( up to one week) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
6 Minute Walk Test
Secondary outcome measures
10 Meter Walk Test
5 Time Sit to Stand
Activities Balance Confidence Scale-16
+2 more
Other outcome measures
1 Repetition Maximum Strength Testing (Knee Extension)
1 Repetition Maximum Strength Testing (Leg press)
Lower Extremity Limb Circumference

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Interventional CohortExperimental Treatment1 Intervention
Blood Flow Restricted High Intensity Treadmill Training at 70% limb occlusion 2x weekly for 16 Sessions totaling a minimum of 75 minutes weekly.
Group II: Control CohortActive Control1 Intervention
High-Intensity Treadmill Training 2x weekly for 16 Sessions totaling a minimum of 75minutes weekly.

Find a Location

Who is running the clinical trial?

MedStar National Rehabilitation NetworkLead Sponsor
13 Previous Clinical Trials
4,560 Total Patients Enrolled
8 Trials studying Stroke
936 Patients Enrolled for Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants currently being recruited for this ongoing medical study?

"The data available on clinicaltrials.gov indicates that this specific research investigation is not currently seeking participants. Initially uploaded on March 1, 2024, with the most recent update also noted for the same date. Despite this trial no longer soliciting candidates, there are a noteworthy 1504 alternative trials actively pursuing eligible individuals at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Blood Flow Restricted High-Intensity Treadmill Training on Independently Ambulating Chronic Ischemic CVA Survivors
Jane Alkhazov 2024. "Blood Flow Restricted High-Intensity Treadmill Training on Independently Ambulating Chronic Ischemic CVA Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06214494.
All > Autonomic Dysfunction
~10 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top